Director
Merck & Co., Inc.
West Point, Pennsylvania
Linlin Luo has worked in the Pharmaceutical Industry for about 15 years focusing in the area of regulated bioanalytical (BA) testing of biologic therapeutics. As a BA lead she has been contributing to pharmacokinetic (PK), immunogenicity (IMG), and neutralizing antibody (NAb) assay development and validation, in support of numerous preclinical and clinical studies for many critical programs, such as Opdivo and Yervoy. Linlin is currently a Principle Scientist at the Global Bioanalytics of Merck, taking the scientific leader role for a team of scientists who develop bioanalytical assays to support regulated bioanalysis for immunogenicity assessments.
Monday, October 23, 2023
3:00 PM – 4:00 PM ET
ADA Strategies to Address Potential Target Interference in Support of a FIH Study Sprays
Tuesday, October 24, 2023
3:30 PM – 3:45 PM ET